Navidea Biopharmaceuticals Enters into Letter of Intent with Cardinal Health for the Sale of Lymphoseek® in North America Sep 6, 2016
Navidea Biopharmaceuticals to Announce Second Quarter 2016 Financial Results on August 4, 2016 Jul 28, 2016
Navidea Receives IRB Approval for its Lymphoseek® Rheumatoid Arthritis Clinical Trial Protocol Jul 19, 2016
Navidea Announces Presentation of Results Demonstrating Performance of Lymphoseek® in Breast Cancer at SNMMI Jun 16, 2016
